TABLE 3.
Differences in responses between subgroups
| At-transplant interviews (n = 15) vs posttransplant interviews (n = 20) | |
|---|---|
| Only raised in at-transplant interviews | None |
| Only raised in posttransplant interviews | |
| Reasons to accept an HIV D+ organ | Helping others on waitlist by accepting HIV D+ organ |
| Impact of transplant | Improved cognitive function posttransplant |
| Kidney recipients (n = 13) vs liver and SLK recipients (n = 9) | |
| Only raised by kidney recipients | |
| Reasons to accept an HIV D+ organ | Discontinue or avoid dialysis |
| Impact of transplant (general) | Discontinue or avoid dialysis |
| Ability to travel | |
| Improved level of activity | |
| Anticipated risks and concerns about HIV D+ organ | Effect of HIV and HIV therapies on organ function |
| Coinfection | |
| Quality of HIV+ donor organ | |
| Only raised by liver recipients | |
| Reasons to accept an HIV D+ organ | Mortality on waitlist |
| Help others on the waitlist | |
| Experienced stigma | |
| Interviews in 2017–2018 (n = 14) vs 2019–2020 (n = 21) | |
| Only raised by interviews in 2017–2018 | |
| Reasons to accept an HIV D+ organ | Healthier at transplant than if waited for HIV D– organ |
| Only raised by interviews in 2019–2020 | |
| Perceptions regarding stigma | Combat stigma |
| Anticipated risks and concerns about HIV D+ organ | Anonymity |
| Needing to change HIV medications posttransplant | |
| Coinfection | |
| Impact of immunosuppression on HIV | |
| Reasons to accept an HIV D+ organ | Help others on the waitlist |
D–, negative donor; D+, positive donor; HIV+, HIV positive; SLK, simultaneous liver kidney.